WallStSmart
PHG

Koninklijke Philips NV ADR

NYSE: PHG · HEALTHCARE · MEDICAL DEVICES

$27.16
+0.46% today

Updated 2026-06-05

Market cap
$25.76B
P/E ratio
23.04
P/S ratio
1.46x
EPS (TTM)
$1.15
Dividend yield
3.82%
52W range
$21 – $32
Volume
1.2M

Koninklijke Philips NV ADR (PHG) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$26.98B$26.84B$26.39B$23.19B$25.42B$22.58B$24.79B$23.33B$21.39B$24.24B$24.52B$17.78B$18.12B$17.15B$17.31B$17.16B$17.83B$18.17B$18.02B$17.83B
Revenue growth (YoY)-0.5%-1.7%-12.1%+9.6%-11.2%+9.8%-5.9%-8.3%+13.3%+1.1%-27.5%+1.9%-5.4%+1.0%-0.9%+3.9%+1.9%-0.8%-1.0%
Cost of revenue$18.68B$17.65B$17.92B$15.11B$15.87B$13.93B$15.38B$13.64B$13.19B$14.39B$13.90B$9.60B$9.57B$9.20B$9.40B$9.99B$10.63B$10.72B$10.25B$9.78B
Gross profit$8.30B$9.18B$8.47B$8.08B$9.55B$8.65B$9.41B$9.69B$8.21B$9.86B$10.61B$8.18B$8.55B$7.95B$7.91B$7.17B$7.19B$7.45B$7.77B$8.06B
Gross margin30.8%34.2%32.1%34.8%37.6%38.3%38.0%41.5%38.4%40.7%43.3%46.0%47.2%46.4%45.7%41.8%40.4%41.0%43.1%45.2%
R&D$1.67B$1.63B$1.78B$1.63B$1.58B$1.61B$1.81B$1.73B$1.64B$1.93B$2.02B$1.76B$1.76B$1.79B$1.91B$1.81B$2.09B$1.89B$1.75B$1.70B
SG&A$3.66B$4.13B$1.01B$734.00M$735.00M$841.00M$798.00M$949.00M$747.00M$1.21B$845.00M$577.00M$631.00M$586.00M$630.00M$599.00M$671.00M$608.00M$582.00M$628.00M
Operating income$1.18B$1.85B$54.00M$614.00M$2.06B$-269.00M$1.03B$1.99B$486.00M$992.00M$1.88B$1.52B$1.72B$1.37B$1.26B$553.00M$-1.53B$-115.00M$529.00M$1.42B
Operating margin4.4%6.9%0.2%2.6%8.1%-1.2%4.2%8.5%2.3%4.1%7.7%8.5%9.5%8.0%7.3%3.2%-8.6%-0.6%2.9%8.0%
EBITDA$2.01B$2.71B$656.00M$2.31B$3.63B$1.03B$1.94B$3.10B$1.79B$1.75B$2.35B$2.65B$2.79B$2.62B$2.75B$2.00B$115.00M$1.04B$1.85B$2.64B
EBITDA margin7.5%10.1%2.5%10.0%14.3%4.6%7.8%13.3%8.4%7.2%9.6%14.9%15.4%15.3%15.9%11.6%0.6%5.7%10.3%14.8%
EBIT$1.18B$1.86B$-534.00M$839.00M$2.21B$-422.00M$507.00M$1.75B$600.00M$473.00M$1.09B$1.62B$1.71B$1.72B$1.69B$673.00M$-1.49B$-220.00M$460.00M$1.51B
Interest expense$4.79B$5.75B$246.00M$391.00M$336.00M$352.00M$352.00M$400.00M$415.00M$467.00M$569.00M$263.00M$264.00M$209.30M$193.80M$164.00M$244.00M$306.00M$337.00M$332.34M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$5.38B$4.17B$-92.00M$410.00M$1.45B$-1.29B$226.00M$1.17B$415.00M$645.00M$1.45B$1.66B$1.09B$1.17B$1.19B$3.32B$-1.61B$-466.00M$-702.00M$895.00M
Net income growth (YoY)-22.4%-102.2%+545.7%+252.7%-189.6%+117.5%+417.3%-64.5%+55.4%+124.5%+14.4%-34.2%+7.1%+1.7%+179.6%-148.4%+71.0%-50.6%+227.5%
Profit margin20.0%15.6%-0.3%1.8%5.7%-5.7%0.9%5.0%1.9%2.7%5.9%9.3%6.0%6.8%6.9%19.3%-9.0%-2.6%-3.9%5.0%

Frequently asked questions

What is Koninklijke Philips NV ADR's revenue?

Koninklijke Philips NV ADR's trailing twelve-month revenue is $17.64B, and consensus projects about $22.29B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is PHG?

In its most recent fiscal year, PHG ran a gross margin of 45.18%, an operating margin of 7.98%, and a net margin of 5.02%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does PHG generate?

PHG produced $893.00M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PHG's balance sheet healthy?

PHG holds $2.79B in cash and equivalents against $6.93B in long-term debt, on $10.96B of shareholder equity. That debt is best read against the cash flow the business throws off each year.